ニュース

Trump Administration Releases New COVID-19 Vaccine Plan: What to Know
In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...
FDA announces change to future Covid-19 vaccine approvals that will limit fall boosters
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
FDA makes controversial changes to COVID-19 vaccine framework
The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...
New Trump vaccine policy limits access to COVID shots
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
FDA will limit COVID-19 vaccine to those over 65 or at high risk
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
MAHA Influencer Slams Trump Admin COVID Vaccine Update—'Really Unfortunate'
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
FDA offers new guidelines to shift COVID vaccine focus to high-risk groups
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
FDA plans to limit COVID vaccine to only high-risk people. Florida cases, deaths in 2025
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.